HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Development of a cytotoxic T-cell assay in rabbits to evaluate early immune response to human T-lymphotropic virus type 1 infection.

Abstract
Human T-lymphotropic virus type 1 (HTLV-1) infection causes adult T-cell lymphoma/leukemia (ATL) following a prolonged clinical incubation period, despite a robust adaptive immune response against the virus. Early immune responses that allow establishment of the infection are difficult to study without effective animal models. We have developed a cytotoxic T-lymphocyte (CTL) assay to monitor the early events of HTLV-1 infection in rabbits. Rabbit skin fibroblast cell lines were established by transformation with a plasmid expressing simian virus 40 (SV40) large T antigen and used as autochthonous targets (derived from same individual animal) to measure CTL activity against HTLV-1 infection in rabbits. Recombinant vaccinia virus (rVV) constructs expressing either HTLV-1 envelope surface unit (SU) glycoprotein 46 or Tax proteins were used to infect fibroblast targets in a (51)Cr-release CTL assay. Rabbits inoculated with Jurkat T cells or ACH.2 cells (expressing ACH HTLV-1 molecule clone) were monitored at 0, 2, 4, 6, 8, 13, 21, and 34 wk post-infection. ACH.2-inoculated rabbits were monitored serologically and for viral infected cells following ex vivo culture. Proviral load analysis indicated that rabbits with higher proviral loads had significant CTL activity against HTLV-1 SU as early as 2 wk post-infection, while both low- and high-proviral-load groups had minimal Tax-specific CTL activity throughout the study. This first development of a stringent assay to measure HTLV-1 SU and Tax-specific CTL assay in the rabbit model will enhance immunopathogenesis studies of HTLV-1 infection. Our data suggest that during the early weeks following infection, HTLV-1-specific CTL responses are primarily targeted against Env-SU.
AuthorsRashade A H Haynes 2nd, Andrew J Phipps, Brenda Yamamoto, Patrick Green, Michael D Lairmore
JournalViral immunology (Viral Immunol) Vol. 22 Issue 6 Pg. 397-405 (Dec 2009) ISSN: 1557-8976 [Electronic] United States
PMID19951176 (Publication Type: Journal Article, Research Support, N.I.H., Extramural)
Chemical References
  • Gene Products, env
  • Gene Products, tax
  • Recombinant Fusion Proteins
  • Retroviridae Proteins, Oncogenic
  • gp46 protein, Human T-cell leukemia virus type I
  • tax protein, Human T-lymphotrophic virus 1
Topics
  • Animals
  • Cell Line, Transformed
  • Cytotoxicity Tests, Immunologic (methods)
  • Female
  • Fibroblasts (virology)
  • Gene Products, env (genetics, immunology)
  • Gene Products, tax (immunology)
  • Genes, pX
  • HTLV-I Infections (immunology)
  • Human T-lymphotropic virus 1 (immunology, physiology)
  • Humans
  • Jurkat Cells (immunology)
  • Major Histocompatibility Complex (immunology)
  • Proviruses (isolation & purification)
  • Rabbits
  • Recombinant Fusion Proteins (immunology)
  • Retroviridae Proteins, Oncogenic (genetics, immunology)
  • T-Lymphocytes, Cytotoxic (immunology)
  • Time Factors
  • Virus Replication

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: